Protocols
1 protocol(s) meet the specified criteria
Drug: Entinostat
Protocol No.TitleStatus
LCCC1729Breaking Innate PD-1 Inhibitor (PD1i) Resistance Using Epigenetic Modifiers; Antitumor Efficacy and Correlative Analyses of Entinostat plus Pembrolizumab in Non-Inflamed Metastatic Melanoma (MM)Open